Fecal Microbiome Signatures May Predict Pancreatic Ductal Adenocarcinoma
A team of investigators examined the potential of fecal and salivary microbiota to serve as diagnostic biomarkers for pancreatic ductal adenocarcinoma.
A team of investigators examined the potential of fecal and salivary microbiota to serve as diagnostic biomarkers for pancreatic ductal adenocarcinoma.
Investigators assessed the prevalence of alcohol-related gastrointestinal and liver disorders before vs during the COVID-19 pandemic.
Investigators assessed the incidence of acute pancreatitis from 1961 onward, as stratified by age, sex, and cause of pancreatitis.
Investigators reviewed current pancreatic cancer screening practices and offered recommendations to overcome challenges associated with improving screening efficacy.